Prosecution Insights
Last updated: November 04, 2026
Application No. 18/471,549

RECOVERABLE AND SELF-EXPANDING SHORT-FRAME VALVE SUITABLE FOR AORTIC VALVE REGURGITATION

Final Rejection §103
Filed
Sep 21, 2023
Priority
Oct 14, 2022 — CN 202211260451.X
Examiner
SPENCER, MAXIMILIAN TOBIAS
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Fuwai Hospital Chinese Academy Of Medical Sciences
OA Round
2 (Final)
34%
Grant Probability
At Risk
3-4
OA Rounds
0m
Est. Remaining
67%
With Interview

Examiner Intelligence

Grants only 34% of cases
34%
Career Allowance Rate
24 granted / 70 resolved
-35.7% vs TC avg
Strong +33% interview lift
Without
With
+32.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
30 currently pending
Career history
121
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
61.4%
+21.4% vs TC avg
§102
18.1%
-21.9% vs TC avg
§112
17.7%
-22.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 70 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-10 are pending and examined below Response to Arguments The remarks of 07/27/2026 have been fully considered but they are not persuasive. Applicant argues that the prior art doesn't explicitly teach or disclose all of the elements of amended claim 1. In particular applicant argues the following claim language: “an axial length ratio of the divergent portion to the adduction portion of 2:1 “an axial length ratio of the second portion to the first portion is 1:3 Regarding the first bullet point - Figulla discloses below shows a divergent portion that has twice the axial length of the adduction portion as shown in annotated Figure 1. Regarding the second bullet point - Figulla discloses a first portion (i.e. the section proximal of the waist) that is three times as long in the axial direction as the second portion (i.e. the section distal the waist) as indicated in annotated Fig. 1 Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-10 is/are rejected under 35 U.S.C. 103 as being unpatentable over CN 114271992 (Chen) in view of US 2007/0142906 (Figulla) Regarding claim 1, Chen discloses a recoverable and self-expanding short-frame valve suitable for aortic valve regurgitation (Fig. 1), comprising: a tubular frame (Fig. 1, see also ¶0012 of the attached translation) and valve leaflets (¶0031, “three leaflets”) sutured to an inner periphery of the tubular frame (¶0031, “sewing three leaflets of the inner circumference of the tubular frame”), the tubular frame having a plurality of hollow grids (¶0031, “the tubular frame is provided with a plurality of follow grids) thereon to cause the tubular frame to contract to a delivery configuration or expand to a use configuration in a radial direction (¶0031, “shrink to the conveying shape or expand to the use shape in the radial direction”), the tubular frame comprising a first portion (Fig. 1, 1) and a second portion (Fig. 1, 2) integrally formed and coaxially arranged (¶0032), a waist portion (Fig. 1, 3) being formed at the junction of the first portion and the second portion when the tubular frame is in the use configuration (see Fig. 1, wherein 3 is at junction of 2 and 1), and the second portion being divergently arranged in a direction away from the waist portion, wherein (see Fig. 1, wherein 2 is divergently arranged in a direction away from 3): the first portion in the direction away from the waist portion comprises a divergent portion and an adduction portion (see annotated Fig. 1 provided below) an end of the adduction portion away from the waist portion is formed with a plurality of endpoints (see Fig. 1), PNG media_image1.png 663 805 media_image1.png Greyscale Chen discloses a divergent portion and an addiction portion (see annotated Fig. 1 below) but doesn't explicitly teach or disclose an axial length ratio of the divergent portion to the adduction portion of 2: 1, an axial length ratio of the second portion to the first portion is 1: 3; and connection sections being arranged on at least five of the endpoints and configured to be detachably connected to steel wires of a valve delivery system Figulla discloses a stent (Fig. 1) comprising a divergent portion and an adduction portion (see annotated Fig. 1 below), with an axial length ratio of the divergent portion to the adduction portion of 2::1 (see annotated Fig. 1 below); an axial length ratio of the second portion to the first portion is 1: 3 (see annotated Fig. 1 below) and connection sections being arranged on at least five of the endpoints (see Fig. 1 below, wherein 4 is arranged on a least 5 endpoints) and configured to be detachably connected to steel wires of a valve delivery system (¶0052, wherein “engagement with a catheter system” corresponds to configured to be detachably connected to steel wires of a valve delivery system) PNG media_image2.png 619 888 media_image2.png Greyscale It would have been obvious to a person of ordinary skill in the art, before the effective filing date of the claimed invention to modify the axial length ratios of the divergent portion to the adduction portion and the second portion to the first portion to be 2:1 and 1:3 respectively as well as connection sections on five endpoints configured to be detachably connected to steel wires of a valve delivery system , as taught by Figulla, in order to anchor the stent in the patient’s heart as precisely as possible (Figulla, abstract) while still allowing for recover and/or replacement. Regarding claim 2, Chen further discloses a stud integrally formed on the endpoints (Fig. 1, 121, see also ¶0033 of translation wherein 121 corresponds to a stud because it prevents aortic perforation) PNG media_image3.png 724 630 media_image3.png Greyscale Regarding claim 3, Chen discloses a plurality of endpoints (see rejection of claim 1) but doesn't explicitly teach or disclose wherein the number of the endpoints is 5-10. Figulla discloses wherein the number of the endpoints is 5-10 (see annotated Fig. 1 below, wherein five to ten endpoints are shown) PNG media_image4.png 801 992 media_image4.png Greyscale It would have been obvious to a person of ordinary skill in the art, before the effective filing date of the claimed invention to modify the frame of Chen with five to ten endpoints, as taught by Figulla, in order to sufficient attachment points for repositioning and/or reconfiguration of the frame. Regarding claim 4, Chen further discloses a cross section where the junction of the adduction portion and the divergent portion is located is a first cross section (see annotated Fig. 1, “first cross section”), and a cross section where an end of the second portion away from the waist portion is located is a second cross section (annotated Fig. 1, “second cross section”); and diameter of the first cross section is greater than that of the section cross section when the tubular frame is in the use configuration (See annotated Fig. 1 below, wherein the diameter of the annotated first cross section is larger than the diameter of the annotated second cross section) PNG media_image5.png 630 803 media_image5.png Greyscale Regarding claim 5, Chen further discloses an outer tectorial membrane (Fig. 1, 4) covered on the peripheries of the second portion and a portion of the divergent portion near the waist portion PNG media_image6.png 635 805 media_image6.png Greyscale Regarding claim 6, Chen further discloses a divergence angle of the second portion in the direction away from the waist portion is 5°-10° (¶0014, see also claim 2) Regarding claim 7, Chen further discloses that the tubular frame is made of a nickel-titanium alloy (¶0035, “the tubular frame of the embodiment is made of nickel-titanium alloy material”) Regarding claim 8, Chen further discloses a plurality of positioning mark points are uniformly distributed in a circumferential direction of the waist portion (¶0016, “waist circumference is uniformly distributed with a plurality of locating mark points”) Regarding claim 9, Chen further discloses a positioning mark point is made of gold (¶0017, “Preferably, the locating mark point is made of gold material”) Regarding claim 10, Chen further discloses an outer tectorial membrane is made of PET (¶0018, “Preferably, the material of the outer coating is PET material”) Conclusion THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MAXIMILIAN TOBIAS SPENCER whose telephone number is (571)272-8382. The examiner can normally be reached M-F 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jerrah Edwards can be reached on 408.918.7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MAXIMILIAN TOBIAS SPENCER/Examiner, Art Unit 3774 /JERRAH EDWARDS/Supervisory Patent Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Sep 21, 2023
Application Filed
Apr 28, 2026
Non-Final Rejection mailed — §103
Jul 27, 2026
Response Filed
Oct 20, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12667472
METHOD AND SYSTEM TO ACTIVATE LIMB MOVEMENT IN AMPUTEES
4y 3m to grant Granted Jun 30, 2026
Patent 12636169
PROSTHETIC FOOT
3y 10m to grant Granted May 26, 2026
Patent 12616590
ASSISTIVE DEVICE WITH HYBRID CONTROL SYSTEMS
3y 11m to grant Granted May 05, 2026
Patent 12508010
Medical Devices for Repairing Perforations in Tissue, Methods of Manufacturing Medical Devices, and Methods of Implanting a Medical Device
4y 8m to grant Granted Dec 30, 2025
Patent 12370066
DEVICE AND METHOD FOR RESISTIVE TORQUE CONTROL IN A MAGNETORHEOLOGICAL ACTUATOR USING A RECOVERY PULSE
2y 8m to grant Granted Jul 29, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
34%
Grant Probability
67%
With Interview (+32.7%)
3y 2m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 70 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month